Form 4: Bioxytran Director Alan Hoberman Reports Acquisition and Disposal of Preferred Stock
SEC Form 4 Filing
Director Alan Hoberman reports acquiring and disposing of Bioxytran, Inc. preferred stock on October 25, 2024.
Summary
- On October 25, 2024, Alan Hoberman, a director of Bioxytran, Inc., engaged in transactions involving the company's preferred stock.
- Hoberman acquired 20,619 shares of preferred stock at a price of $0.46 per share.
- Following these transactions, Hoberman directly owns 269,667 shares of Bioxytran preferred stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reporting a director's stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Stakeholder Impact
- The transaction may be of interest to shareholders as it reflects insider activity.
Key Dates
| Date | Description |
|---|---|
| 10/25/2024 | Date of transaction: Alan Hoberman acquired 20,619 shares of preferred stock and disposed of an unspecified amount. |
| 10/28/2024 | Date of signature on the report by Alan Hoberman. |
Keywords
Form 4, Bioxytran, Director, Hoberman, Preferred Stock, BIXT, Acquisition, Disposal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.